Estimates Revisions Tempest Therapeutics, Inc.
Stocks
TPST
US87978U2078
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.8316 USD | +0.31% |
|
+7.47% | -71.02% |
| 09-23 | Tempest Therapeutics, Inc. Announces Appointment of Nancy Freda-Smith to Its Board of Director and Chair of Audit Committee | CI |
| 09-16 | Top Premarket Gainers | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- TPST Stock
- Consensus Tempest Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
